Ultragenyx Pharmaceutical Inc. (LON:0LIF)
London
· Delayed Price · Currency is GBP · Price in USD 39.50
+2.88 (7.86%)
At close: Jul 2, 2025
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of 2.76 billion as of July 3, 2025. Its market cap has decreased by -2.84% in one year.
Market Cap
2.76B
Enterprise Value
3.00B
Revenue
457.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.50
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from 746.36M to 2.76B, an increase of 269.56%. That is a compound annual growth rate of 12.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.11B |
| Shell | 154.45B |
| HSBC Holdings | 153.63B |
| Unilever | 111.76B |
| Rolls-Royce Holdings | 78.76B |
| British American Tobacco p.l.c. | 75.81B |
| Rio Tinto Group | 74.32B |
| RELX PLC | 70.60B |